12 research outputs found

    Quantile-Quantile(QQ) plots on SNP set enrichment.

    No full text
    <p>QQ-plots of SNP set enrichment test. Solid line represents normal distribution and black dots represent data distribution of p-values for eSNPs representing genes within the gene set of interest. Deviation of the data from the solid line indicates a non-normal distribution. Plots are shown for the top ranking gene sets A: published mRNA profiling signatures from infarcted tissue and B: implicated causal genes from the Global Lipid Genetics GWAS Consortium.</p

    Beneficiary Baseline Characteristics By Study Period.

    No full text
    <p>SD, Standard deviation; NE, Northeast; NC, North Central</p><p><sup>a</sup> Mean monthly percentage of population with medical encounters in the 3-months prior</p><p>Beneficiary Baseline Characteristics By Study Period.</p

    Monthly Mean Incidence (95% CI) Per 100 000 Commercially Insured Children: Overall and by Predictor Subgroups

    No full text
    <p>CI, Confidence Interval; NE, Northeastern; NC, North Central</p><p><sup>a</sup> Based on medical encounters in the 3-months prior to index drug date</p><p><sup>b</sup> Patients who visited “neither” specialties were omitted from table</p><p>Monthly Mean Incidence (95% CI) Per 100 000 Commercially Insured Children: Overall and by Predictor Subgroups</p

    Regional plots for the association of SNPs with MI in the region of <i>QKI</i>.

    No full text
    <p>Regional plots for the association of SNPs with MI in the region of <i>QKI</i>.</p

    Study design for identification and validation of SNPs associated with MI and CHD.

    No full text
    <p>Study design for identification and validation of SNPs associated with MI and CHD.</p

    Association of the known SNPs for coronary artery disease with incident MI and CHD in Stage I.

    No full text
    <p>Association of the known SNPs for coronary artery disease with incident MI and CHD in Stage I.</p
    corecore